多发性内分泌腺瘤病1型和VHL综合征相关胰腺神经内分泌肿瘤切除术后的外科与肿瘤学结局:大型多中心队列研究
该多中心回顾性队列研究比较了散发性、MEN1相关和VHL相关胰腺神经内分泌肿瘤(PNET)患者行胰腺切除术后的结局。尽管MEN1和VHL患者更年轻、胰头和多灶病变更多,MEN1肿瘤更大且功能性肿瘤比例更高,但各组淋巴结清扫率、阳性淋巴结率、Clavien-Dindo≥3级并发症及无进展生存和总生存均无显著差异。
要点
- MEN1和VHL相关PNET患者比散发性患者更年轻,胰头及多灶病变更常见。
- MEN1患者功能性肿瘤比例更高(19.2% vs 10.9%散发 vs 3.8% VHL,p=0.045)。
- 尽管R2切除率MEN1组较高(9.6% vs 2.6%散发 vs 3.8% VHL),各组生存无显著差异。
核心结论
- 尽管散发性、MEN1相关和VHL相关PNET患者在年龄、肿瘤大小、R状态和手术方式上存在显著差异,但术后并发症、无进展生存和总生存相似。
研究设计与样本
- 回顾性分析美国5家机构2000年至2023年行胰腺切除术的PNET患者,纳入所有成人MEN1和VHL相关PNET患者及具有总生存和肿瘤分级数据的成人散发性PNET患者。
- 共纳入1527例患者,其中MEN1 73例,VHL 26例,散发性1428例;多数为男性(54%),中位年龄59岁(IQR 50-68),中位随访53个月。
主要发现
- MEN1和VHL患者显著更年轻,且胰头和多灶病变更多。
- MEN1患者功能性肿瘤更多(19.2% vs 10.9%散发 vs 3.8% VHL,p=0.045)。
- 肿瘤以1/2级为主(97%),但MEN1肿瘤更大(2.8 vs 2.3 cm散发 vs 2.5 cm VHL,p=0.03)。
- R2切除率散发性2.6%、MEN1 9.6%、VHL 3.8%。
- 淋巴结清扫率(86%-92%)、阳性淋巴结率(24%-31%)和Clavien-Dindo≥3级并发症在各组间相似。
临床怎么用
- 对于MEN1和VHL相关PNET患者,胰腺切除术后的外科和肿瘤学结局与散发性患者相似,支持在适当选择下进行手术。
- MEN1患者功能性肿瘤比例较高,术前应评估激素相关症状。
- 尽管MEN1患者R2切除率较高,但生存无差异,提示需个体化评估手术策略。
局限性
- 回顾性研究设计。
- MEN1和VHL组样本量较小(分别为73例和26例)。
- 中位随访53个月,可能需要更长期随访评估生存差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pancreatic neuroendocrine tumors (PNETs) are associated with MEN type 1 (MEN1) and von Hippel-Lindau (VHL) syndrome, yet data about surgical outcomes in these patients is lacking. This study compared outcomes after pancreatectomy across a large cohort of sporadic, MEN1-, and VHL-PNET patients. STUDY DESIGN: Retrospective analysis of pancreatectomies for PNETs performed at 5 institutions in the US between 2000 and 2023 as part of the PAncreatic Neuroendocrine Disease Alliance. All adult patients with MEN1- and VHL-associated PNETs were included. Adult sporadic PNET patients with overall survival and tumor grade data were included. RESULTS: Of 1,527 patients, 73 had MEN1, 26 had VHL, and 1,428 had sporadic PNETs. Majority were male (54%) with median age of 59 years (interquartile range 50 to 68 years). Median follow-up was 53 months. MEN1 and VHL patients were significantly younger and had more pancreatic head and multifocal disease compared with sporadic patients. MEN1 patients had more functional tumors (19.2% vs 10.9% sporadic vs 3.8% VHL, p= 0.045). Formal resection was most common, whereas enucleation occurred in 9.4%, 6.8%, and 3.8% of sporadic, MEN1-, and VHL-PNETs, respectively. Tumors were predominantly grade 1/2 (97%) but larger in MEN1 (2.8 vs 2.3 cm sporadic vs 2.5 cm VHL, p = 0.03). R2 resection occurred in 2.6% of sporadic, 9.6% of MEN1-, and 3.8% of VHL-PNETs. Rates of lymphadenectomy (86% to 92%), positive lymph nodes (24% to 31%), and Clavien-Dindo grade ≥3 complications were similar across groups. Progression-free survival and overall survival among groups were not significantly different. CONCLUSIONS: Despite significant differences in age, tumor size, R status, and surgical approach, outcomes including postoperative complications, progression-free survival and overall survival after surgery are similar between sporadic, MEN1-, and VHL-associated PNET patients at 5-year follow-up.
引用
- Zhang L, Ventin M, Arya S, et al. Surgical and Oncologic Outcomes After Pancreatectomy for Pancreatic Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 and von Hippel-Lindau Syndrome: A Large, Multi-Institutional, Cohort Study. J Am Coll Surg. 2026. PMID: 41642264. doi:10.1097/XCS.0000000000001829
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。